Is it appropriate to make a small sterile skin incision to decompress subcutaneous emphysema in the neck caused by a pneumothorax before inserting an internal jugular central venous catheter?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Do Not Make a Skin Incision to Decompress Subcutaneous Emphysema Before IJ Central Line Placement

The primary treatment for subcutaneous emphysema from pneumothorax is to address the underlying pneumothorax with proper chest tube drainage, not to make skin incisions for decompression. Making a skin incision in the neck before placing an internal jugular central line is not a standard or recommended approach and introduces unnecessary infection risk.

Treatment Algorithm for Subcutaneous Emphysema from Pneumothorax

First-Line Management (Conservative)

The BTS guidelines clearly state that subcutaneous emphysema associated with pneumothorax "is generally of cosmetic importance only, subsiding after a few days" 1. Treatment is usually conservative 1.

The key is addressing the source:

  • Ensure proper chest tube function (not kinked, blocked, or clamped)
  • Verify adequate tube size for the air leak
  • Consider that a small tube with a very large leak may cause surgical emphysema 1

When Intervention Is Needed (Life-Threatening Cases Only)

Skin incision decompression is reserved only for life-threatening situations where subcutaneous emphysema causes:

  • Acute airway obstruction
  • Thoracic compression leading to respiratory compromise 1

In these rare emergencies, the BTS guidelines note that "tracheostomy, skin incision decompression, and insertion of large bore modified subcutaneous chest drains have all been used" 1.

Specific Considerations for IJ Central Line Placement

Site Selection Priority

The ASA guidelines on central venous access emphasize:

  • Select an insertion site that is not contaminated or potentially contaminated 2
  • Use real-time ultrasound guidance for internal jugular vein cannulation 2
  • Maximal sterile barriers are essential 2

Why Not to Make an Incision

Creating a skin incision introduces several problems:

  1. Infection Risk: The ESPEN guidelines emphasize that sites with better dressing feasibility have lower infection rates 3. Making an incision creates an additional wound that increases contamination risk.

  2. Not Standard Practice: Neither the ASA 2020 guidelines 2 nor the Association of Anaesthetists 2025 guidelines 4 recommend or mention making skin incisions to decompress subcutaneous emphysema before central line placement.

  3. Addresses Wrong Problem: The subcutaneous air is a symptom, not the barrier. Ultrasound guidance can successfully identify the internal jugular vein even with subcutaneous emphysema present.

Practical Approach When Facing This Scenario

If Subcutaneous Emphysema Is Mild to Moderate:

  • Proceed with ultrasound-guided IJ line placement using standard sterile technique
  • The air in tissues does not prevent successful ultrasound visualization of the vein
  • Use real-time ultrasound to confirm needle tip entering the vein and wire placement 2

If Subcutaneous Emphysema Is Massive and Life-Threatening:

  1. First, address the airway if there is respiratory compromise (may require tracheostomy) 1
  2. Optimize chest tube management: ensure proper function, consider larger bore tube, apply suction if not already done 1
  3. Only then consider skin incisions (infraclavicular, not at the IJ site) if truly life-threatening 5, 6
  4. Delay central line placement until the patient is stabilized if possible

Alternative Central Access Sites:

If neck subcutaneous emphysema is severe and you need urgent central access:

  • Consider femoral vein access as an alternative 2
  • Consider subclavian approach if anatomy permits 2
  • The supraclavicular fossa sites may have less emphysema than the neck 3

Key Pitfalls to Avoid

  • Never clamp a bubbling chest tube - this can worsen subcutaneous emphysema and convert simple pneumothorax to tension pneumothorax 1
  • Don't create unnecessary wounds - each incision is a potential infection source
  • Don't delay definitive pneumothorax treatment - fix the source, not just the symptom
  • Don't assume you can't use ultrasound - subcutaneous air rarely prevents adequate vessel visualization for experienced operators

In summary: Address the pneumothorax properly with chest tube management, use ultrasound guidance for the IJ line through intact skin, and reserve skin incisions only for true life-threatening airway compromise from massive emphysema.

Related Questions

What are the risks of placing an internal jugular central venous catheter in a mechanically ventilated patient with subcutaneous emphysema over the insertion site from a pneumothorax who already has a chest tube?
Is internal jugular central venous catheter insertion contraindicated in a patient with subcutaneous emphysema of the neck secondary to pneumothorax?
What is the appropriate management for subcutaneous emphysema that develops after removal of a chest tube?
What is the management of subcutaneous emphysema post cardiac arrest?
Does subcutaneous emphysema without an obvious pneumothorax indicate the presence of a pneumothorax?
For a computed tomography coronary angiography performed in the morning, should I hold apixaban (Eliquis) the night before a possible left heart catheterization if the CT coronary angiogram is positive?
What is the recommended technique for inserting a large‑bore esophageal suction tube (orogastric/nasogastric) to divert massive vomiting before endotracheal intubation when suction‑assisted laryngoscopy airway decontamination (SALAD) cannot keep up?
Can you summarize the International Working Group on the Diabetic Foot (IWGDF) guidelines for foot risk classification, assessment, and management in patients with diabetes?
What is the recommended dosing and administration schedule for obinutuzumab (Gazyva) and lenalidomide in chronic lymphocytic leukemia?
Are there any pharmacologic interactions between Sinemet (carbidopa/levodopa) and Merrem (ranibizumab), and is dose adjustment required?
What are the risks of placing an internal jugular central venous catheter in a mechanically ventilated patient with subcutaneous emphysema over the insertion site from a pneumothorax who already has a chest tube?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.